Jaguar Health, Inc. (JAGX) vs Nuwellis, Inc. (NUWE)

A side-by-side comparison of Jaguar Health, Inc. and Nuwellis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — JAGX vs NUWE

growth of $100 · dividends reinvested · last 8y
JAGX -100.0% (-86.1%/yr)NUWE -100.0% (-88.5%/yr)JAGX compounded faster over this window
020406080100Start $1002017201920212023$0$0
JAGX NUWE

JAGX vs NUWE: by the numbers

  • •NUWE is the larger company ($3M vs $2M market cap).
  • •Both run net losses; NUWE's is the smaller (-123.38% vs -131.76% net margin).
  • •JAGX grew revenue faster over the past five years (31.88% vs 1.48% CAGR).

Metrics side by side

Valuation

MetricJAGXNUWE
P/S ratio0.090.29
P/B ratio0.38N/A

Profitability

MetricJAGXNUWE
Gross margin67.21%69.69%
Operating margin-391.87%-140.62%
Net margin-131.76%-123.38%
ROE-554.01%N/A
ROIC-110.81%-238.32%

Growth (annualized)

MetricJAGXNUWE
Revenue CAGR (5Y)31.88%1.48%

Frequently asked

Which has grown faster, JAGX or NUWE?
Over the past five years, JAGX grew revenue faster — JAGX at a 31.88% CAGR versus NUWE at 1.48%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.